CME, ICE push U.S. regulators to scrutinize Hyperliquid over manipulation risks

CME and ICE are urging US regulators to investigate Hyperliquid due to concerns over market manipulation risks. The regulators are being pushed to scrutinize Hyperliquid's activities. This scrutiny may have significant implications for the company.